Methadone Hydrochloride Dtf Rosemont Pharmaceuticals (Methadone Hydrochloride)

Methadone Hydrochloride is an opioid agonist used in opioid dependence treatment and chronic pain management.

• Opioid dependence: provides maintenance therapy that stabilizes patients, reduces illicit opioid use, and diminishes withdrawal symptoms and cravings.
• Chronic pain: offers long‑acting analgesic effect for severe, persistent pain when other treatments are insufficient or not tolerated.
• Opioid detoxification: employed in medically supervised detox programs to safely taper patients off higher‑potency opioids and prevent relapse.
• Opioid use disorder in pregnancy: may be used under specialist supervision to manage dependence while minimizing fetal exposure.

• Methadone Hydrochloride acts as a full agonist at the mu‑opioid receptors in the central nervous system, producing analgesia and reducing withdrawal symptoms. By binding to these receptors, it inhibits neuronal excitability and modulates pain pathways, leading to decreased perception of pain and suppression of opioid cravings. Its long half‑life provides sustained receptor activation, allowing once‑daily dosing for maintenance therapy.

Methadone Hydrochloride may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects

• Constipation: reduced gastrointestinal motility leading to hard stools.
• Nausea: feeling of queasiness often accompanied by an urge to vomit.
• Drowsiness: increased sedation or fatigue during daily activities.
• Sweating: excessive perspiration unrelated to temperature or exertion.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing that can be life‑threatening.
• QT interval prolongation: cardiac electrical disturbance that may predispose to arrhythmias.
• Severe allergic reaction: symptoms such as rash, itching, swelling, dizziness, or anaphylaxis.

When prescribing Methadone Hydrochloride, clinicians should consider several safety measures.

• Assess patient history: evaluate prior opioid use, respiratory disorders, and cardiac conditions.
• Monitor cardiac function: obtain baseline ECG and periodically check QT interval.
• Avoid abrupt discontinuation: taper dose gradually to prevent withdrawal.
• Use caution in hepatic impairment: adjust dosing as liver function may affect metabolism.
• Avoid concomitant CNS depressants: limit use of benzodiazepines, alcohol, or other sedatives.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone Hydrochloride interacts with several drug classes that may alter its safety or efficacy.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines): increase risk of respiratory depression and sedation.
• MAO inhibitors: can precipitate severe hypotension or serotonin syndrome.
• QT‑prolonging agents (e.g., certain antiarrhythmics): heighten risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely)

• Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise methadone plasma levels.
• CYP3A4 inducers (e.g., rifampin): may reduce methadone effectiveness.
• Serotonergic drugs (e.g., SSRIs): monitor for signs of serotonin excess.